Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, ...
Gastric (stomach) cancer remains one of the most common and deadly cancers in East Asia, including Korea. Yet despite its high prevalence, it has received far less molecular attention than colorectal ...
Researchers have identified the mechanism by which cancer cells create their own growth signals to proliferate, independent ...
Anthocyanin-rich purple foods contain plant pigments that influence antioxidant and inflammatory pathways and are linked in human and experimental studies to measurable benefits in vascular function ...
Tesamorelin is a synthetic 44–amino acid analog of growth hormone–releasing hormone (GHRH) that has attracted attention outside the experimental domain for its potential as a research tool. This ...
Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that following evaluation of interim data from ...
Clinical Trials Arena on MSN
Immuneering progresses MAPK inhibitor in lung and pancreatic cancer
The biotech will now take atebimetinib to mid- and late-stage trials in NSCLC and pancreatic cancer, respectively.
Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...
It is a central question in neuroscience to understand how different regions of the brain interact, how strongly they "talk" ...
Singapore has one of the highest life expectancies in the world, yet many individuals spend almost a decade in poor health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results